You are here:
» Patient-reported adverse effects when switching from oral...
About Aarhus University
Patient-reported adverse effects when switching from oral to subcutaneous administration of methotrexate: A prospective, multicenter, paired cohort study
Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
DOI
- https://doi.org/10.1016/j.jaad.2021.12.039
Final published version
- Jon Erik Fraes Diernæs, University of Southern Denmark ,
- Charles B Kromann, European Reference Network for Rare Skin Diseases (ERN-skin) ,
- Mikkel Boel
- Anette Bygum, University of Southern Denmark ,
- Gregor Borut Ernst Jemec, University of Copenhagen
| Original language | English |
|---|---|
| Journal | Journal of the American Academy of Dermatology |
| Volume | 87 |
| Issue | 4 |
| Pages (from-to) | 920-922 |
| Number of pages | 3 |
| ISSN | 0190-9622 |
| DOIs | |
| Publication status | Published - Oct 2022 |
- Administration, Oral, Antirheumatic Agents/adverse effects, Cohort Studies, Humans, Injections, Subcutaneous, Methotrexate/adverse effects, Patient Reported Outcome Measures, Prospective Studies, Treatment Outcome
Research areas
See relations at Aarhus University Citationformats
ID: 264095260